Publicaciones en colaboración con investigadores/as de Mayo Clinic (17)

2023

  1. Myosin post-translational modifications and function in the presence of myopathy-linked truncating MYH2 mutations

    American journal of physiology. Cell physiology, Vol. 324, Núm. 3, pp. C769-C776

2022

  1. A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis

    EMBO molecular medicine, Vol. 14, Núm. 3, pp. e14552

  2. Intelligence, educational attainment, and brain structure in those at familial high-risk for schizophrenia or bipolar disorder

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 414-430

  3. NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 793-805

  4. Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions

    Journal of Alzheimer's disease : JAD, Vol. 88, Núm. 4, pp. 1203-1228

2021

  1. The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 12, pp. e1064-e1073

  2. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

    Journal of Thoracic Oncology, Vol. 16, Núm. 4, pp. 686-696

2020

  1. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 10, pp. 1599-1610

  2. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    Journal of Thoracic Oncology, Vol. 15, Núm. 5, pp. 709-740

  3. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 4, pp. 499-519

  4. Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research

    Journal of Alzheimer's disease : JAD, Vol. 73, Núm. 3, pp. 1143-1156

  5. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 9, pp. 1409-1424

2019

  1. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

    Nature Communications, Vol. 10, Núm. 1

  2. Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report

    Journal of Oncology Pharmacy Practice, Vol. 25, Núm. 4, pp. 998-1002

2018

  1. Multinodular and vacuolating neuronal tumor of the cerebrum. A rare entity. New case and review of the literature

    Neurocirugia

2017

  1. Angiocentric Glioma in an Elderly Patient: Case Report and Review of the Literature

    World Neurosurgery, Vol. 97, pp. 755.e5-755.e10

2014

  1. Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar i disorder: A randomized, double-blind, placebo-controlled, multicenter trial

    Journal of Clinical Psychiatry, Vol. 75, Núm. 10, pp. 1054-1061